Active Ingredient: BORTEZOMIB
Proprietary Name: VELCADE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS, SUBCUTANEOUS
Strength: 3.5MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N021602
Product Number: 001
Approval Date: May 13, 2003
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information